PD1/PD-L1 Experienced
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma (NCT04955743) | Yale University | 2022-02-09 |
Track PD1/PD-L1 Experienced automatically
Every clearance here is in the API, with alerts when new ones post.